Defining Oligometastatic Pancreatic Cancer: A Systematic Review and Critical Synthesis of Consensus. Leonhardt CS, Stamm TA, Hank T, Prager GW, Strobel O. ESMO Open. 2023 Nov. doi: 10.1016/j.esmoop.2023.102067
Smoking impairs the effect of neoadjuvant FOLFIRINOX on postresection survival in pancreatic cancer. Leonhardt CS, Pils D, Motaz Q, Gustorff C, Sahora K, Klaiber U, Warshaw AL, Prager G, Ferrone CR, Lillemoe KD, Schindl M, Strobel O, Fernandez-del Castillo C, Hank T. Eur J Cancer. 2023 Nov:193:113293. doi: 10.1016/j.ejca.2023.113293
Prognostic impact of resection margin status on survival after neoadjuvant treatment for pancreatic cancer - Systematic review and meta-analysis. Leonhardt CS, Hank T, Pils D, Gustorff C, Sahora K, Schindl M, Verbeke CS, Strobel O, Klaiber U. International Journal of Surgery. 2023 Oct. doi: 10.1097/JS9.0000000000000792
Patient reported outcomes of duodenum-preserving pancreatic head resection in chronic pancreatitis: high effectivity is impaired by prolonged non-surgical management. Leonhardt CS, Niesen W, Pils D, Angelova Y, Hank T, Kaiser J, Scheele C, Hinz U, Hackert T, Büchler MW, Strobel O. HPB. 2023 Oct 5:S1365-182X(23)01943-3. doi: 10.1016/j.hpb.2023.10.002.
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review. Eshmuminov D, Aminjonov B, Palm RF, Malleo G, Schmocker RK, Abdallah R, Yoo C, Shaib WL, Schneider MA, Rangelova E, Choi YJ, Kim H, Rose JB, Patel S, Wilson GC, Maloney S, Timmermann L, Sahora K, Rössler F, Lopez-Lopez V, Boyer E, Maggino L, Malinka T, Park JY, Katz MHG, Prakash L, Ahmad SA, Helton S, Jang JY, Hoffe SE, Salvia R, Taieb J, He J, Clavien PA, Held U, Lehmann K. Ann Surg Oncol. 2023 Jul;30(7):4417-4428. doi: 10.1245/s10434-023-13353-2. Epub 2023 Apr 5.
Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment. Jomrich G, Gruber M, Gruber ES, Mühlbacher J, Radosavljevic S, Wilfing L, Winkler D, Prager G, Reiterer C, Kabon B, Haslacher H, Sahora K, Schindl M. J Visc Surg. 2023 Jun 28:S1878-7886(23)00115-7. doi: 10.1016/j.jviscsurg.2023.06.004.
The Revised R Status is an Independent Predictor of Postresection Survival in Pancreatic Cancer After Neoadjuvant Treatment. Leonhardt CS, Pils D, Motaz Q, Jomrich G, Assawasirisin C, Klaiber U, Sahora K, Warshaw AL, Ferrone CR, Schindl M, Lillemoe KD, Strobel O, Fernandez-del Castillo C, Hank T. Ann Surg. 2023 Apr 12. doi: 10.1097/SLA.0000000000005874.
Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study. Leonhardt CS, Kinny-Köster B, Hank T, Habib JR, Shoucair S, Klaiber U, Cameron JL, Hackert T, Wolfgang CL, Büchler MW, He J, Strobel O. Ann Surg Oncol. 2023 Apr;30(4):2433-2443. doi: 10.1245/s10434-022-12901-6
ASO Author Reflections: Outcomes Support Aggressive Surgery for Early-Onset Pancreatic Cancer. Leonhardt CS, Kinny-Köster B, He J, Strobel O. Ann Surg Oncol. 2023 Apr;30(4):2444-2445. doi: 10.1245/s10434-022-12948-5.
ASO Visual Abstract: Resected Early-Onset Pancreatic Cancer—Practices and Outcomes in an International Dual-Center Study. Leonhardt CS, Kinny-Köster B, Hank T, Habib JR, Shoucair S, Klaiber U, Cameron JL, Hackert T, Wolfgang CL, Büchler MW, He J, Strobel O. Ann Surg Oncol. 2023 Apr;30(4):2446-244. doi: 10.1245/s10434-022-13037-3.
The relationship of hospital and surgeon volume indicators and post-operative outcomes in pancreatic surgery: a systematic literature review, meta-analysis and guidance for valid outcome assessment. Fischer C, Alvarico SJ, Wildner B, Schindl M, Simon J. HPB (Oxford). 2023 Apr;25(4):387-399. doi: 10.1016/j.hpb.2023.01.008. Epub 2023 Jan 23.
Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma. Leonhardt CS, Hinz U, Kaiser J, Hank T, Tjaden C, Bergmann F, Hackert T, Bücher MW, Strobel O. Eur J Surg Oncol. 2023 Jan;49(1):113-121. doi: 10.1016/j.ejso.2022.08.003
Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer. Hank T, Klaiber U, Hinz U, Schütte D, Leonhardt CS, Bergmann F, Hackert T, Jäger D, Büchler MW, Strobel O.Ann Surg. 2022 Jun 27;277(5):e1089-98. doi: 10.1097/SLA.0000000000005481.
Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis. Leonhardt CS, Niesen W, Kalkum E, Klotz R, Hank T, Buchler MW, Strobel O, Probst P. BJS Open. 2022 Mar 8;6(2):zrac010 doi: 10.1093/bjsopen/zrac010.
Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience. Surci N, Bassi C, Salvia R, Marchegiani G, Casetti L, Deiro G, Bergmann C, Walenta K, Tamandl D, Schindl M, Sahora K, Mühlbacher. J. Dig Surg. 2022;39(4):169-175. doi: 10.1159/000526263. Epub 2022 Aug 2.
IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy. Kaiser J, Scheifele C, Hinz U, Leonhardt CS, Hank T, Koenig AK, Tjaden C, Hackert T, Bergmann F, Buchler MW, Strobel O. Eur J Surg Oncol. 2022 Jun;48(6):1309-20. doi.org/10.1016/j.ejso.2021.12.009.
Surgery for chronic pancreatitis: the comparison of two high-volume centers reveals lack of a uniform operative management. Surci N, Bassi C, Salvia R, Marchegiani G, Casetti L, Deiro G, Bergmann C, Tamandl D, Schindl M, Mühlbacher J, Sahora K. Langenbecks Arch Surg. 2021 Oct 1. doi: 10.1007/s00423-021-02335-1.
[Surgery for periampullary pancreatic cancer]. Hank T, Klaiber U, Sahora K, Schindl M, Strobel O. Chirurg. 2021 Sep;92(9):776-787. doi: 10.1007/s00104-021-01462-1.
Imaging of inflammatory disease of the pancreas. Bastati N, Kristic A, Poetter-Lang S, Messner A, Herold A, Hodge JC, Schindl M, Ba-Ssalamah A. Br J Radiol. 2021 Jul 1;94(1123):20201214. doi: 10.1259/bjr.20201214.
The faith of non-surveilled pancreatic cysts: a bicentric retrospective study. Surci N, Marchegiani G, Andrianello S, Pollini T, Mühlbacher J, Jomrich G, Richwien P, Tamandl D, Schindl M, Bassi C, Salvia R, Sahora K. Eur J Surg Oncol. 2021 Jun 8:S0748-7983(21)00569-2. doi: 10.1016/j.ejso.2021.06.007.
A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer. Kloesch B, Ionasz V, Paliwal S, Hruschka N, Martinez de Villarreal J, Öllinger R, Mueller S, Dienes HP, Schindl M, Gruber ES, Stift J, Herndler-Brandstetter D, Lomberk GA, Seidler B, Saur D, Rad R, Urrutia RA, Real FX, Martinelli P. Gut. 2021 Apr 12:gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
Metachronous hepatic resection for liver only pancreatic metastases. Schwarz C, Fitschek F, Primavesi F, Stättner S, Margonis GA, Weiss MA, Stavrou GA, Oldhafer KJ, Kornprat P, Wundsam H, Fischer I, Längle F, Függer R, Hauer A, Klug R, Kieler M, Prager G, Schindl M, Stremitzer S, Bodingbauer M, Sahora K, Kaczirek K. Surg Oncol. 2020 Dec;35:169-173. doi: 10.1016/j.suronc.2020.08.005.
Applied precision medicine in metastatic pancreatic ductal adenocarcinoma. Taghizadeh H, Müllauer L, Mader RM, Schindl M, Prager GW. Ther Adv Med Oncol. 2020 Jul 10;12:1758835920938611. doi: 10.1177/1758835920938611.
The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Gruber ES, Jomrich G, Kaider A, Gnant M, Sahora K, Schindl M. Ann Surg Oncol. 2020 Jun;27(6):2017-2024. doi: 10.1245/s10434-019-08161-6.
Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M. J Gastrointest Surg. 2020 Mar;24(3):610-618. doi: 10.1007/s11605-019-04187-z.
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K. PLoS One. 2019 May 6;14(5):e0215915. doi: 10.1371/journal.pone.0215915.
Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy. Schindl M, Függer R, Götzinger P, Längle F, Zitt M, Stättner S, Kornprat P, Sahora K, Hlauschek D, Gnant M; Austrian Breast and Colorectal Cancer Study Group. Br J Surg. 2018 Jun;105(7):811-819. doi: 10.1002/bjs.10840.